Home Search
drug development - search results
If you're not happy with the results, please do another search
GE crops: Biotech and novel food safety conflicts
Dr Richard E. Goodman of the Food Allergy Research and Resource Program discusses GE crops and the US FDA, EFSA and CODEX international guidelines
Climate change, environmental justice and COVID-19
Here, Professor Pamela Lein at University of California, Davis, explains the 'perfect storm' unfolding in the intersection of climate change, environmental justice and COVID-19.
Will 2021 see the UK’s cannabis industry bloom?
John Binns & David Hardstaff from BCL Solicitors LLP, reveal if 2021 will be the year that sees the UK’s cannabis industry bloom.
SWINOSTICS: Field-diagnostics in pig farming
Here, R&D Director Alessandro Giusti details the work of the Horizon 2020 funded SWINOSTICS project to tackle viruses causing epidemics in pig farming.
New technologies for knowledge translation in cancer
Ahmed Samir Abdelhafiz and Zisis Kozlakidis both shed light on new technologies for knowledge translation in cancer.
Medical devices: Technology addressing medical wellbeing
Bernard Ross, CEO of Sky Medical Technology, looks at how wearable medical technology can address some of the most critical medical issues of the 21st Century.
Building readiness for innovative health technologies
Senior Researcher in Social Science Michael Morrison explains why disruptive technologies need institutional and systemic readiness to truly realise the benefits of healthcare innovation.
Drinking tea & coffee reduces risk of death in type-2 diabetes by 63%
A new study has found that drinking 4 cups of green tea or 2 cups of coffee per day reduces the risk of death in type-2 diabetes by 63%.
Some countries can’t vaccinate population against COVID until 2023
In February, 16% of the world's population pre-ordered 70% of available COVID vaccines - now, researchers at Colombia University reveal that some poorer countries won't be able to vaccinate their population until 2023.
Pan African Food Security and Food Safety Issues
Food Insecurity is a major issue in the recent pandemic for people in countries throughout Africa and most of the world.
The importance of the life science sector to the post-COVID economic recovery
Dean Billington, Chief Operating Officer at Brains Bioceutical, discusses the pivotal role of the life science sector in spearheading the post-Covid economic recovery and why driving forward R&D and innovation should be the nation’s top priority.
Trial finds York/Hull leishmaniasis vaccine is safe
A new vaccine, developed by researchers at the Hull York Medical School, to treat leishmaniasis has proved to be safe in the first clinical trials.
What are the symptoms of digital eye strain and how can it be treated?
Dr Deborah Lee, Dr Fox Online Pharmacy, highlights the symptoms of digital eye strain and explains what can be done to treat it.
Johnson & Johnson factory accident damages 15 million vaccine doses
A "human error" created a factory mixup for Johnson & Johnson in Baltimore, Maryland, damaging up to 15 million vaccine doses - but this does not impact doses that are ready for use.
Open Access Government April 2021
The April 2021 edition of Open Access Government speaks about government policy issues globally, like COVID-19, health & social care, research & innovation, finance, digital transformation, agriculture, environment and energy.
Curative approach to severe autoimmune diseases
Andrew Mackie, VP Business Development tells us how Imcyse, a Belgian immunotherapy expert, seeks a curative approach to severe autoimmune diseases.
Reconstructive Dentistry: New biomaterials & technologies
Mutlu Özcan, Prof. Dr Dr h.c., PhD from the University of Zürich, highlights Reconstructive Dentistry through new biomaterials and technologies, including the associated changes and challenges.
A simple prescription for healing chronic disease
Dr Shireen Kassam MBBS, FRCPath, PhD, dipIBLM, Founder and Director of Plant-Based Health Professionals UK, explains a simple prescription for health as a remedy to chronic disease.
From insulin to immunotherapy: A century of discovery
Dr Faye Riley, Senior Research Communications Officer at Diabetes UK, highlights how immunotherapy is raising hopes for the next big breakthrough in type 1 diabetes.
How global evidence can improve outcomes for spinal patients
Everard Munting, President of EUROSPINE, explains why sharing knowledge about spinal treatments on a global scale is the most effective way to develop best practice and enable early interventions.